Company Performance: INAF's financial health, including revenue, profit margins, and debt levels, greatly influences its stock price. Strong performance usually leads to increased investor confidence and higher stock valuation. Industry Trends: The overall health and growth prospects of the pharmaceutical industry in Indonesia impact INAF. Positive industry trends can boost INAF's stock, while negative trends can depress it. Economic Conditions: Indonesia's economic growth, inflation rates, and interest rates can affect INAF's profitability and investor sentiment. A strong economy usually supports higher stock prices. Government Regulations: Changes in government regulations related to the pharmaceutical industry, such as pricing controls or import restrictions, can significantly impact INAF's earnings and stock value. Market Sentiment: General investor optimism or pessimism about the stock market can influence INAF's stock price, even if the company's fundamentals remain unchanged. Competition: The competitive landscape within the Indonesian pharmaceutical market affects INAF's market share and profitability. Increased competition can put pressure on prices and stock value. Global Factors: Global economic conditions and international trade policies can also affect INAF, especially if it relies on imported raw materials or exports its products.